Norrsken Mind

14.8 Norrsken Mind

Norrsken Mind is a non-profit foundation dedicated to advancing psychedelic science in Europe. The foundation funds high-quality research to investigate the therapeutic potential of psychedelics for mental health disorders, along with non-profit initiatives to lay the foundation for the future integration of these treatments into healthcare.

Norrsken Mind funded Sweden’s first modern psilocybin-assisted therapy trial at Karolinska Institutet in 2020 and continues to support multiple clinical trials, as well as epidemiological and psychological research focused on both the potential risks and the therapeutic benefits of psychedelics.

In addition to funding research, Norrsken Mind promotes public education, stakeholder engagement, and policy dialogue. By offering grants and facilitating partnerships, Norrsken Mind aims to create the necessary conditions for psychedelic treatments to be rigorously studied, responsibly implemented, and accessible to patients in need.

Funding and Support

Norrsken Mind actively works to mobilise philanthropic capital for psychedelic science. The foundation is funded through donations from committed benefactors and its affiliation with the Norrsken Foundation.

• Norrsken is a non-profit, non-partisan, and non-religious foundation founded in 2016 by Niklas Adalberth, co-founder of Klarna. Guided by a belief in entrepreneurship and new technology as forces that can positively impact the world, Norrsken collaborates with start-ups, researchers, and non-profits globally to address the greatest challenges of our time. It manages Norrsken House hubs in Barcelona, Kigali, and Stockholm. Norrsken’s five funds have raised more than 750m USD to back exceptional entrepreneurs who combine profit with positive global impact.

For more information about funding opportunities and how to apply, visit the Norrsken Mind’s website or contact info@norrskenmind.org.